Cargando…

Combining chemotherapy and autologous peptide‐pulsed dendritic cells provides survival benefit in stage IV melanoma patients

BACKGROUND AND OBJECTIVES: We examined retrospectively whether the combination of standard dacarbazine (DTIC) and/or fotemustine chemotherapy and autologous peptide‐loaded dendritic cell (DC) vaccination may improve survival of stage IV melanoma patients. Furthermore, a small cohort of long‐term sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Eisendle, Klaus, Weinlich, Georg, Ebner, Susanne, Forstner, Markus, Reider, Daniela, Zelle‐Rieser, Claudia, Tripp, Christoph H., Fritsch, Peter, Stoitzner, Patrizia, Romani, Nikolaus, Nguyen, Van Anh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756560/
https://www.ncbi.nlm.nih.gov/pubmed/33197129
http://dx.doi.org/10.1111/ddg.14334

Ejemplares similares